Ramsay Health Care share price on watch amid Bupa contract termination

Ramsay is playing hardball with Bupa…

| More on:
Female doctor with a mask holds out hand in a stop gesture.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Ramsay is terminating its contract with private health insurer Bupa
  • It wants a fairer deal as it battles rising costs and private health insurers watch their profits swell
  • Bupa customers may have to switch health funds to get treatment from Ramsay in the future

The Ramsay Health Care Limited (ASX: RHC) share price will be one to watch on Thursday.

This follows the release of an announcement after the market close today in relation to a contract termination.

Why is the Ramsay share price on watch?

This afternoon Ramsay revealed that it has issued a notice to private health insurance provider Bupa to terminate the Hospital Purchaser Provider Agreement between the two parties.

According to the release, unless a resolution is reached between the parties, Ramsay's contract with Bupa will be terminated with effect from 2 August 2022.

Ramsay appears to believe that private health insurers are not pulling their weight despite accumulating huge profits.

"Costs of providing care have significantly increased for private hospitals over the past two years. On the other hand, health insurers have accumulated profits of $1.8 billion in the calendar year to 31 December 2021," said Ramsay Australia CEO Carmel Monaghan.

What's next?

The release explains that patients booked to be admitted to a Ramsay facility prior to 2 August will not be impacted. After that date, during a legally enforced transitional period, Ramsay will continue to accept benefits paid by Bupa for approved treatments.

However, once the transitional period ends, Bupa insured patients will be required to pay an upfront payment on admission. This will be the difference between the statutory default benefit Bupa is required to pay and Ramsay's hospital treatment costs.

Ms Monaghan said that "Ramsay still hopes to reach agreement with Bupa prior to the contract termination date," but this appears to be far from guaranteed.

The private hospital operator advised that it will be communicating with impacted patients to keep them informed and provide them with options which, in light of the portability rules in the Private Health Insurance Act, include leaving Bupa and changing health funds.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Why are Mesoblast shares jumping 10% to a 52-week high?

This biotech is hitting new highs on Friday. Let's find out why.

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Ansell shares tumble to a 3-month low. Is this a buying opportunity?

Ansell shares have slid to a 3-month low. Could oversold signals point to a buying opportunity for long-term investors?

Read more »

Female scientist working in a laboratory.
Healthcare Shares

These three biotechs show how the sector can produce huge outsized gains, but are they still good value?

These drug developers' shares are trading near 12-month highs.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

This biotech is approaching 20-bagger status within a year and the good news continues to come

This company has just won approval to go ahead with a key clinical trial.

Read more »

An investor sits at a table in front of her laptop with a party hat on her head and a cake next to her symbolising new year's eve but the 4DS Memory share price is plunging so she looks very disappointed and depressed
Healthcare Shares

$5 billion ASX 200 healthcare stock tumbling on CEO exit

Investors are bidding down the ASX 200 healthcare giant on Thursday. Let’s see why.

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »